DiamiR Announces Oral Presentation at AD/PD(TM) 2017
29 mars 2017 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 29, 2017) - DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Samuil...
Dr. Mark Schiller to present “The use of PEER to Personalize Medicine” at IPEG
26 oct. 2016 05h00 HE
|
MYnd Analytics, Inc.
NIJMEGEN, The Netherlands, Oct. 26, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. ("MYnd") (OTCQB:MYAN), Dr. Mark Schiller, Medical Director - MYnd Analytics, will present at the International...
MYnd Analytics presents to the American Legion Committee on PTSD/TBI
12 oct. 2016 05h00 HE
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Oct. 12, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (“MYnd”) (OTCQB:MYAN), which provides a unique set of reference data and analytic tools for clinicians to assist in...
MYnd Analytics, Inc. Announces Ticker Symbol Change to "MYAN"
11 oct. 2016 14h45 HE
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Oct. 11, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. ("MYnd") (OTCQB:MYAN), which provides a unique set of reference data and analytic tools for clinicians to assist...
MYnd Analytics California Centers Receive CMS Approval
10 oct. 2016 05h00 HE
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Oct. 10, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:CNSOD), which provides a unique set of reference data and analytic tools for clinicians to assist in...
EEG is the Wave of the Future: Machine Learning Technology Highlighted in Biological Psychiatry Publication
27 sept. 2016 20h00 HE
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 27, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:CNSOD) announces the publication of “Using Electroencephalography for Treatment Guidance in Major Depressive...
Circulomics Awarded $1.5M Phase II SBIR to Develop Multiplex microRNA Assay
13 mai 2015 09h17 HE
|
Circulomics
BALTIMORE, MD--(Marketwired - May 13, 2015) - Circulomics Inc has been awarded a $1.5M Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH) - National...
DiamiR Announces Presentation at Extracellular Biomarkers Summit 2015
11 mars 2015 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 11, 2015) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Poster Presentation at the Clinical Trials on Alzheimer's Disease 2014
17 nov. 2014 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 17, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Publication and Discusses Merits of Universal Screening Test Based on Organ-Enriched microRNA Signatures
03 nov. 2014 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 03, 2014) - DiamiR Biosciences Corp., a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today the...